A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Clinical trial NCT03768063 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03768063
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2028-07-05
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.